Greg Chodaczek has over 25 years of experience in corporate finance, communications, corporate strategy and equity research. Greg has been instrumental in driving investment decisions across all sectors of healthcare and his Wall Street background spans two decades with both buyside and sell-side leadership roles.
Prior to joining Gilmartin, Greg spent many years as an Equity Research analyst covering the medical technology sector at several emerging growth banks including First Analysis, Sterne Agee CRT and B. Riley & Co where he primarily focused on small and mid-capitalization companies. He began his Wall Street career at Pilgrim Baxter where he eventually led healthcare equity research and managed over $2B in equity assets. Previously, he held several corporate finance positions at UPS and Scientific Atlanta.
Greg received a BS in Finance from Villanova University and an MS in Finance from the Robinson College of Business at Georgia State University.
Interesting Facts About Greg
- Recently adopted a six-year old English Springer Spaniel named Chloe
- Built a 3D printer from scratch
- Plays in a weekly ice hockey league
- Would rather be on the Chesapeake Bay sailing